Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Inspira Technologies Oxy BHN ( (IINN) ) is now available.
On February 11, 2025, Inspira Technologies announced successful results from its collaboration with Ennocure MedTech Ltd., demonstrating their bio-electronic IV dressing technology’s effectiveness in reducing bacterial infections. The ex-vivo testing showed a 95% reduction in bacterial presence within four hours, which could significantly impact infection prevention in critical care settings, addressing common issues with traditional IV dressings. This development represents a crucial milestone for Inspira Technologies, potentially enhancing its position in the life support and respiratory treatment industry.
More about Inspira Technologies Oxy BHN
Inspira Technologies OXY B.H.N. Ltd. is an innovative medical technology company specializing in life support and respiratory treatment. The company has developed the INSPIRA™ ART system, which aims to revolutionize the mechanical ventilation market by allowing patients to remain awake during treatment, and the HYLA™ blood sensor technology for real-time blood monitoring. It targets significant markets, including the $19 billion mechanical ventilation market and the $2.5 billion blood gas analyzer market.
YTD Price Performance: -19.14%
Average Trading Volume: 782,167
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.84M
For a thorough assessment of IINN stock, go to TipRanks’ Stock Analysis page.
